Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Creating the amylin story
Thomas A. Lutz
Appetite (2022) Vol. 172, pp. 105965-105965
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics
Ania M. Jastreboff, Robert F. Kushner
Annual Review of Medicine (2023) Vol. 74, Iss. 1, pp. 125-139
Open Access | Times Cited: 80
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management
Jens J. Holst
Nature Metabolism (2024) Vol. 6, Iss. 10, pp. 1866-1885
Open Access | Times Cited: 19
Mammalian models of diabetes mellitus, with a focus on type 2 diabetes mellitus
Thomas A. Lutz
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 6, pp. 350-360
Closed Access | Times Cited: 34
Pharmacological Support for the Treatment of Obesity—Present and Future
Marcin Kosmalski, Kacper Deska, Bartłomiej Bąk, et al.
Healthcare (2023) Vol. 11, Iss. 3, pp. 433-433
Open Access | Times Cited: 24
Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity
Stjepan Eržen, Gašper Tonin, Dubravka Jurišić‐Eržen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1517-1517
Open Access | Times Cited: 13
Evolution of peptide YY analogs for the management of type 2 diabetes and obesity
Wang Chen, Gong Binbin, Lidan Sun, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106808-106808
Closed Access | Times Cited: 14
Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity
Antonella M. D’Ascanio, Jamie Mullally, William H. Frishman
Cardiology in Review (2023) Vol. 32, Iss. 1, pp. 83-90
Closed Access | Times Cited: 12
The role of amylin, a gut–brain axis hormone, in metabolic and neurological disorders
Tahir Muhammad, Stephen F. Pastore, Katrina V. Good, et al.
FASEB BioAdvances (2025)
Open Access
Amylin is incorporated into extracellular vesicles in an ESCRT-dependent manner and regulates senescence
Sarai Iglesias-Fortes, A. P. M. Lockwood, Carlos González-Blanco, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167699-167699
Closed Access
From the pancreas to the amygdala: new brain area critical for ingestive and motivated behavior control exerted by amylin.
Suyeun Byun, Ivana Marić, Stina Börchers, et al.
iScience (2025) Vol. 28, Iss. 3, pp. 112040-112040
Open Access
Amylin inhibits gastric cancer progression by targeting CCN1 and affecting the PI3K/AKT signalling pathway
Li Liu, Wenxuan Liu, Wenhong Deng
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Intranasal pramlintide matches intraperitoneal effects on food intake and gastric emptying in mice
Milena S Almeida, Mariele Paludetto Sanches, Natália Stinghen Tonet, et al.
Endocrine (2025)
Closed Access
Physiological Appetite Regulation and Bariatric Surgery
Indra Ramasamy
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1347-1347
Open Access | Times Cited: 3
Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long‐acting dual amylin and calcitonin receptor agonist improves insulin‐mediated glycaemic control and controls body weight
Simone Anna Melander, Anna Thorsø Larsen, M.A. Karsdal, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 12, pp. 1829-1842
Closed Access | Times Cited: 3
Cross-seeding enables repurposing of aurein antimicrobial peptides as a promoter of human islet amyloid polypeptide (hIAPP)
Yijing Tang, Dong Zhang, Xiong Gong, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 33, pp. 7920-7932
Closed Access | Times Cited: 7
NN1213 – A Potent, Long-Acting, and Selective Analog of Human Amylin
Kirsten Dahl, Kirsten Raun, Jakob Lerche Hansen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11688-11700
Open Access | Times Cited: 2
Novel Pharmaceuticals in Appetite Regulation: Exploring emerging gut peptides and their pharmacological prospects
Igor Rubinić, Marija Kurtov, Robert Likić
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 2
Tricetin Reduces Inflammation and Acinar Cell Injury in Cerulein-Induced Acute Pancreatitis: The Role of Oxidative Stress-Induced DNA Damage Signaling
Máté Nagy‐Pénzes, Zoltán Hajnády, Zsolt Regdon, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1371-1371
Open Access | Times Cited: 9
Phytoconstituents of Ashwagandha as potential inhibitors of human islet amyloid polypeptide (hIAPP): an in silico investigation
Nandeshwar, Janmejaya Rout, Smita Manjari Panda, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 20, pp. 11020-11036
Closed Access | Times Cited: 5
Type‐2 Diabetes, Pancreatic Amylin, and Neuronal Metabolic Remodeling in Alzheimer's Disease
Noah S Leibold, James R. Bain, Florin Despa
Molecular Nutrition & Food Research (2023) Vol. 68, Iss. 13
Open Access | Times Cited: 4
Converting the Amyloidogenic Islet Amyloid Polypeptide into a Potent Nonaggregating Peptide Ligand by Side Chain-to-Side Chain Macrocyclization
Margaryta Babych, Michael L. Garelja, Phuong Trang Nguyen, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 37, pp. 25513-25526
Closed Access | Times Cited: 1
The overexpression of human amylin in pancreatic β cells facilitate the appearance of amylin aggregates in the kidney contributing to diabetic nephropathy
Sarai Iglesias-Fortes, Carlos González-Blanco, Alicia García-Carrasco, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Pharmacotherapy for chronic obesity management: a look into the future
Mariana Abdel-Malek, Lisa Yang, Alexander D. Miras
Internal and Emergency Medicine (2023) Vol. 18, Iss. 4, pp. 1019-1030
Open Access | Times Cited: 3
A model of subcutaneous pramlintide pharmacokinetics and its effect on gastric emptying: Proof-of-concept based on populational data
Clara Furió-Novejarque, Iván Sala-Mira, José-Luis Díez, et al.
Computer Methods and Programs in Biomedicine (2023) Vol. 244, pp. 107968-107968
Closed Access | Times Cited: 3
Body Fat Depletion: the Yin Paradigm for Treating Type 2 Diabetes
Jingjing Zhu, John Wilding
Current Atherosclerosis Reports (2023) Vol. 26, Iss. 1, pp. 1-10
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top